Read More 1 minute read Funding News News Trace Neuroscience Launches with $101M to Target ALS and Neurodegenerative Diseases Key Highlights $101M Series A funding led by Third Rock Ventures and others, supporting ALS and neurodegenerative therapies. UNC13A-focused… byChris-Anne RoqueNovember 15, 2024